{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:12:23Z","timestamp":1793419943975,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015613","name":"Lille University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008487","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006510","name":"Association pour la Recherche sur la Scl\u00e9rose Lat\u00e9rale Amyotrophique et autres Maladies du Motoneurone","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004100","name":"Labex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015872","name":"University of Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107414","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:15:40Z","timestamp":1777011340000},"page":"107414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Blood-based biomarkers of ferroptosis in Parkinson's disease"],"prefix":"10.1016","volume":"224","author":[{"given":"Vincent","family":"Huin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Cailliau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Poupelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gar\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dutheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Beauval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Hainque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Eusebio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Benatru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brefel-Courbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maltete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Giordana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Tir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Thobois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Brandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9chir","family":"Jarraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Hopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rascol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nbd.2026.107414_bb0005","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.nbd.2026.107414_bb0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2021.04.010","article-title":"Ferritinophagy and ferroptosis in the management of metabolic diseases","volume":"32","author":"Ajoolabady","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.nbd.2026.107414_bb0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/ars.2011.4429","article-title":"Lipid peroxidation product 4-Hydroxy-2-Nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of \u03b1-Synuclein","volume":"18","author":"Bae","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41531-022-00384-x","article-title":"Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson\u2019s disease","volume":"8","author":"Batzu","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia Nigra and dystrophic axons in putamen of Parkinson\u2019s brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107414_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"issue":"10","key":"10.1016\/j.nbd.2026.107414_bb0035","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/acn3.50897","article-title":"\u0391-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"6","author":"Bongianni","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107414_bb0040","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"Brigelius-Floh\u00e9","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"3","key":"10.1016\/j.nbd.2026.107414_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","article-title":"A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and alzheimers diseased brains","volume":"65","author":"Connor","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107414_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","article-title":"Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson\u2019s disease and its progression: disease and staging biomarkers and new drug targets","volume":"617","author":"De Farias","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.nbd.2026.107414_bb0060","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.27001","article-title":"Tau\/\u03b1-synuclein ratio and inflammatory proteins in Parkinson\u2019s disease: an exploratory study","volume":"32","author":"Delgado-Alvarado","year":"2017","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00702-019-02138-1","article-title":"Conservative iron chelation for neurodegenerative diseases such as Parkinsons disease and amyotrophic lateral sclerosis","volume":"127","author":"Devos","year":"2020","journal-title":"J. Neural Transm."},{"issue":"8569","key":"10.1016\/j.nbd.2026.107414_bb0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased Nigra l iron content in postmortem parkinsonian brain","volume":"330","author":"Dexter","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia Nigra is increased in Parkinsons disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","article-title":"Decreased ferritin levels in brain in parkinsons disease","volume":"55","author":"Dexter","year":"1990","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0085","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and ither neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107414_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","article-title":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders","volume":"111","author":"Di Domenico","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.nbd.2026.107414_bb0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2026.107414_bb0100","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an Iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2026.107414_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u0391-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"6180","key":"10.1016\/j.nbd.2026.107414_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinsons disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/molecules26040881","article-title":"Selenium biofortification: roles, mechanisms, responses and prospects","volume":"26","author":"Hossain","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.nbd.2026.107414_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent Hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.nbd.2026.107414_bb0130","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.3390\/ijms241210021","article-title":"ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries","volume":"24","author":"Jia","year":"2023","journal-title":"IJMS"},{"issue":"5","key":"10.1016\/j.nbd.2026.107414_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp Neurobiol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-08-0900","article-title":"Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts","volume":"160","author":"Kotronen","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.nbd.2026.107414_bb0150","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0155","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/antiox12040918","article-title":"The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases","volume":"12","author":"Lee","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0160","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/etm.2022.11572","article-title":"Effects of brain factor-7\u00ae against motor deficit and oxidative stress in a mouse model of MPTP-induced Parkinson\u2019s disease","volume":"24","author":"Lee","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","article-title":"A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion","volume":"19","author":"Li","year":"1997","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.nbd.2026.107414_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: a biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nbd.2026.107414_bb0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies","volume":"8","author":"Magalh\u00e3es","year":"2022","journal-title":"npj Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107414_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107414_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.nbd.2026.107414_bb0195","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinsons disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12291-009-0017-y","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"24","author":"Nikam","year":"2009","journal-title":"Indian J. Clin. Biochem."},{"issue":"6","key":"10.1016\/j.nbd.2026.107414_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson\u2019s disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"issue":"6\u20137","key":"10.1016\/j.nbd.2026.107414_bb0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia Nigra in Parkinson\u2019s disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-008-0438-3","article-title":"Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Power","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107414_bb0225","series-title":"Oxidative Stress and Neuroprotection","first-page":"229","article-title":"Impact of selenium, iron, copper and zinc in on\/off Parkinson\u2019s patients on L-dopa therapy","author":"Qureshi","year":"2006"},{"key":"10.1016\/j.nbd.2026.107414_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135873","article-title":"Metals associated neurodegeneration in Parkinson\u2019s disease: insight to physiological, pathological mechanisms and management","volume":"753","author":"Raj","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00401-024-02758-2","article-title":"Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury","volume":"147","author":"Ryan","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107414_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-017-0624-1","article-title":"Prion-like seeding of misfolded \u03b1-Synuclein in the brains of dementia with Lewy body patients in RT-QUIC","author":"Sano","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.nbd.2026.107414_bb0250","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1096\/fj.201600424","article-title":"Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism","volume":"30","author":"Schweizer","year":"2016","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2026.107414_bb0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0891-5849(98)00021-5","article-title":"(E)-4-Hydroxy-2-Nonenal may be involved in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Selley","year":"1998","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson\u2019s disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"6645","key":"10.1016\/j.nbd.2026.107414_bb0270","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u0391-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"71","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nbd.2026.107414_bb0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.nbd.2026.107414_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Sig Transduct Target Ther."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2026.107414_bb0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2026.107414_bb0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.parkreldis.2021.02.008","article-title":"Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson\u2019s disease: an 8-year longitudinal study","volume":"85","author":"Ye","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.nbd.2026.107414_bb0300","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.nbd.2026.107414_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae130","article-title":"Neuroimaging and plasma evidence of early white matter loss in Parkinson\u2019s disease with poor outcomes","volume":"6","author":"Zarkali","year":"2024","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.nbd.2026.107414_bb0310","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"issue":"55","key":"10.1016\/j.nbd.2026.107414_bb0315","doi-asserted-by":"crossref","first-page":"117349","DOI":"10.1007\/s11356-023-30337-7","article-title":"Association between blood selenium with parkinson\u2019s disease in the US (NHANES 2011\u20132020)","volume":"30","author":"Zeng","year":"2023","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"12","key":"10.1016\/j.nbd.2026.107414_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083060","article-title":"Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson\u2019s disease","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:30:41Z","timestamp":1785151841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"alternative-id":["S0969996126001592"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107414","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based biomarkers of ferroptosis in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107414"}}